VO2 Max and the Watt Test: What Your Score Means, Normal Ranges for Women, and Drugs That Distort Results
At a glance
- Test name / Watt test (cycle ergometer) or treadmill VO2 max; both measure maximal oxygen uptake in mL/kg/min
- Top longevity predictor / Low cardiorespiratory fitness carries a higher all-cause mortality risk than smoking, hypertension, or obesity in women (CRF Consensus Statement, Mayo Clin Proc 2016)
- Normal range for reproductive-age women / 30-40 mL/kg/min (average); above 40 is above average
- Perimenopause drop / VO2 max declines roughly 1% per year after age 25 and accelerates near the menopause transition
- Pregnancy impact / VO2 max expressed per kg body weight falls as gestational weight increases; testing is generally deferred until 6 weeks postpartum
- Key drug classes that distort results / beta-blockers, calcium-channel blockers, selective serotonin reuptake inhibitors, GLP-1 agonists, iron-deficiency anemia drugs (or the anemia itself), and hormonal therapies
- Pregnancy safety of testing / maximal exercise testing is not routinely recommended during pregnancy; submaximal protocols only with obstetric clearance
What the Watt Test and VO2 Max Actually Measure
VO2 max is the maximum rate at which your body can consume oxygen during all-out exercise, expressed in milliliters of oxygen per kilogram of body weight per minute (mL/kg/min). The Watt test is a specific incremental cycle-ergometer protocol, most common in European and sports-medicine settings, where resistance increases by a fixed number of watts every minute until you cannot continue. Your peak oxygen consumption at that point is your VO2 max.
Think of it as your engine's ceiling. A higher ceiling means your cardiovascular system, lungs, muscles, and red blood cells are collectively doing their jobs very efficiently.
Why It Matters More Than You Might Expect
The connection between VO2 max and longevity is not subtle. A 2016 expert consensus statement published in Mayo Clinic Proceedings pooled data from more than 1.4 million participants and concluded that low cardiorespiratory fitness was responsible for more deaths than obesity, diabetes, smoking, or hypertension combined. For women specifically, each 1-MET improvement in fitness (roughly 3.5 mL/kg/min) was associated with a 13% reduction in all-cause mortality.
The American Heart Association's 2016 scientific statement formally recommended that cardiorespiratory fitness be treated as a clinical vital sign, alongside blood pressure and resting heart rate. Most primary care practices have been slow to adopt this. If your provider has never measured or estimated your VO2 max, that is worth raising at your next visit.
How the Test Is Done
The Watt test protocol typically starts at 20-50 watts on a stationary bike and increases by 20-25 watts every minute. You wear a face mask connected to a metabolic cart that analyzes the oxygen and carbon dioxide content of every breath. The test ends when you hit volitional exhaustion or a predetermined heart rate threshold.
Submaximal alternatives, including the Astrand-Rhyming cycle test and the 6-minute walk test, estimate VO2 max from your heart rate response and require less equipment. These are the versions more likely to appear in a standard clinical setting or telehealth-adjacent fitness assessment.
Normal VO2 Max Ranges for Women by Life Stage
Women consistently score 15-25% lower than men on absolute VO2 max, primarily because of lower hemoglobin concentration, smaller cardiac stroke volume, and higher percentage of body fat. Ranges designed from mixed-sex data will underestimate your fitness if applied without sex-specific norms.
Reproductive Years (Ages 20-40)
The American College of Sports Medicine publishes sex-specific normative tables. For women aged 20-29, the ranges run roughly:
| Category | mL/kg/min | |---|---| | Superior | >47 | | Excellent | 42-46 | | Good | 37-41 | | Fair | 32-36 | | Poor | <32 |
For women aged 30-39, the "good" band shifts down by about 2 mL/kg/min across the board.
Perimenopause and Menopause (Ages 40-60+)
Estrogen has real physiological effects on oxygen delivery. It increases red blood cell production, supports mitochondrial function in skeletal muscle, and helps maintain cardiac output during exercise. As estrogen falls during perimenopause, you may notice genuine changes in exercise tolerance, not just deconditioning. A 2020 study in Menopause found that postmenopausal women had VO2 max values approximately 8-10% lower than age-matched premenopausal women, even after controlling for physical activity levels.
The practical implication: if you are in perimenopause and your tested VO2 max has dropped, some of that decline is hormone-mediated, not purely a reflection of how much you are exercising. This is clinically meaningful when you are trying to interpret your result or set training targets.
Postpartum
VO2 max per kilogram of body weight falls during pregnancy as gestational weight increases, even when absolute oxygen uptake may actually rise. ACOG's 2020 Physical Activity and Exercise in Pregnancy guidance does not recommend maximal exercise testing during pregnancy. Submaximal testing after 6 weeks postpartum, once cleared by your provider, gives a more interpretable baseline.
Sex-Specific Physiology: Why Your VO2 Max Is Not the Same as a Man's
This section exists because most exercise physiology research was conducted primarily in men, and the default VO2 max norms you find on most fitness trackers and clinical calculators were built on male-predominant datasets. A 2021 review in the Journal of Applied Physiology confirmed that sex differences in VO2 max are driven by at least four overlapping mechanisms:
- Hemoglobin and oxygen-carrying capacity. Women have lower hemoglobin concentrations on average (12-16 g/dL versus 13.5-17.5 g/dL in men), which limits oxygen delivery to working muscle. Iron deficiency, which affects up to 20% of premenopausal women, compounds this further.
- Cardiac output ceiling. Stroke volume in women is smaller relative to body size, though this gap narrows substantially when VO2 max is expressed relative to lean body mass rather than total weight.
- Menstrual phase effects. VO2 max may be slightly but measurably higher in the luteal phase than the follicular phase in some studies, likely because progesterone acts as a respiratory stimulant. The effect size is modest (roughly 2-4%) but large enough to matter if you are tracking progress over time.
- Body composition. Fat-free mass, not total body weight, is the physiologically appropriate denominator. A VO2 max expressed as mL/kg/min penalizes women for having proportionally more essential fat.
Drugs That Distort Your Watt Test or VO2 Max Result
Several drug classes can either artificially depress your measured VO2 max, inflate it, or shift your heart-rate response so that submaximal estimation equations give the wrong answer. This matters both for accurate fitness tracking and for clinical interpretation.
Beta-Blockers: The Biggest Confounder
Beta-blockers (metoprolol, atenolol, carvedilol, propranolol) block the adrenergic drive that raises heart rate during exercise. Because submaximal VO2 max estimation equations rely heavily on heart rate response, any beta-blocker use invalidates those equations entirely. Even during a true maximal Watt test, beta-blockers lower peak heart rate and reduce peak cardiac output, producing a measured VO2 max that may be 10-20% lower than your true physiological ceiling.
If you are on a beta-blocker for hypertension, heart failure, or migraine prevention, your VO2 max result should be interpreted only with that context noted. Direct gas-exchange testing (not heart-rate estimation) is the only valid method.
GLP-1 Receptor Agonists (Semaglutide, Tirzepatide, Liraglutide)
GLP-1 agonists are now among the most commonly prescribed drugs in women's metabolic health. Their effect on VO2 max is a nuanced story. Weight loss itself, a predictable outcome of these medications, typically raises VO2 max expressed in mL/kg/min because the denominator (body weight) decreases. However, if the weight loss includes substantial lean muscle mass, which can occur without adequate protein intake and resistance training, oxygen-consuming muscle tissue is lost and your absolute VO2 max may fall.
A 2023 analysis in Obesity examining semaglutide users found that relative VO2 max improved in parallel with weight loss, but the improvement was attenuated in participants who lost the most lean mass. For women on semaglutide or tirzepatide, getting a VO2 max test at baseline and again after 6 months, alongside a DEXA scan for lean mass, gives you a much cleaner picture of what the drug is actually doing to your fitness.
Hormonal Contraceptives
The evidence here is genuinely mixed, which is worth acknowledging directly. A 2021 meta-analysis in Sports Medicine found no significant difference in VO2 max between combined oral contraceptive users and non-users across 11 trials. However, several smaller studies suggested that high-dose synthetic progestin formulations may slightly blunt the training response, meaning that your VO2 max may improve less with a given exercise program than it would off the pill.
Practically, if you are tracking VO2 max as a training outcome while starting or stopping hormonal contraception, allow 2-3 months of stable hormonal status before drawing conclusions from your results.
Menopausal Hormone Therapy
This is where the sex-specific data gets more interesting. A randomized trial published in Menopause (2018) found that women receiving systemic estrogen therapy showed modest but statistically significant improvements in VO2 max compared to placebo over 6 months, independent of any change in exercise habits. The proposed mechanism is estrogen's support of skeletal muscle mitochondrial function and cardiac output.
This does not mean hormone therapy is a fitness supplement. The clinical indications for menopausal hormone therapy remain vasomotor symptoms and, where appropriate, bone protection. A VO2 max benefit is a secondary finding, not an indication. But if you are postmenopausal, on hormone therapy, and your VO2 max is trending upward, the therapy may be contributing alongside your exercise.
SSRIs and SNRIs
Selective serotonin reuptake inhibitors (sertraline, escitalopram, fluoxetine) and SNRIs (venlafaxine, duloxetine) are frequently prescribed to women for depression, anxiety, premenstrual dysphoric disorder, and perimenopausal mood symptoms. The cardiovascular effect during exercise testing is generally small. A 2019 study in the British Journal of Clinical Pharmacology found no clinically meaningful effect of SSRIs on peak VO2 in adults without heart disease. The more relevant issue is that some women report exercise intolerance or fatigue on SSRIs, which may limit maximal effort on the day of testing.
If you feel you did not give a true maximal effort during your Watt test because of fatigue or motivation, that subjective ceiling is as real as a pharmacological one.
Iron Deficiency and Iron Supplementation
Iron deficiency is the most prevalent nutritional deficiency in premenopausal women globally, affecting an estimated 30-40% of women of reproductive age according to WHO. It directly reduces VO2 max by limiting hemoglobin synthesis and, at the cellular level, impairs iron-containing mitochondrial enzymes involved in oxidative phosphorylation.
Oral iron supplementation, when it corrects a true deficiency, has been shown to raise VO2 max by 3-5 mL/kg/min in iron-deficient women, a clinically meaningful change. A serum ferritin below 30 mcg/L (the threshold associated with impaired exercise capacity, even without overt anemia) is enough to deflate your result. Check ferritin, not just hemoglobin, before concluding your VO2 max reflects your actual aerobic ceiling.
Thyroid Medications and Thyroid Status
Both hypothyroidism and hyperthyroidism alter VO2 max. Untreated hypothyroidism reduces cardiac output, blunts the ventilatory response to exercise, and typically lowers VO2 max by 15-25% below euthyroid levels. Starting levothyroxine and reaching a stable TSH in the normal range partially or fully reverses this. Postpartum thyroiditis, which affects approximately 5-10% of postpartum women, can cause transient hypothyroid or hyperthyroid phases that each distort exercise testing results in different ways.
If your TSH is not in range, VO2 max testing gives you a snapshot of a moving target. Retest after at least 6 weeks on a stable levothyroxine dose.
Statins
Statin-associated muscle symptoms occur in roughly 5-10% of patients and can reduce exercise capacity directly. A subset of women on high-intensity statins (atorvastatin 40-80 mg, rosuvastatin 20-40 mg) report myalgia that limits maximal exertion on a Watt test. A 2013 JAMA Internal Medicine study found that statin use was associated with lower exercise participation, which over time would lower true VO2 max independently of any test-day effect.
How to Raise Your VO2 Max: Evidence-Based Strategies for Women
VO2 max is trainable across every life stage. The gains you achieve at 55 are physiologically real, even if the starting point is lower than it was at 30.
Interval Training Over Steady-State Cardio
High-intensity interval training (HIIT) produces larger VO2 max gains than continuous moderate exercise in head-to-head trials. A 2019 meta-analysis in the British Journal of Sports Medicine found that HIIT raised VO2 max by an average of 4.2 mL/kg/min versus 2.4 mL/kg/min for moderate continuous training over 8-12 weeks. The absolute improvements were comparable in women and men when baseline fitness was matched.
A practical starting format: 4 minutes at 85-95% of max heart rate, 3 minutes easy recovery, repeated 4 times, twice per week.
Resistance Training as a VO2 Max Tool
Resistance training alone raises VO2 max modestly, but it protects the lean muscle mass that determines your absolute oxygen uptake ceiling. For women on GLP-1 agonists or entering menopause, where lean mass loss is a real risk, resistance training is not optional if you care about long-term aerobic capacity.
Iron and Nutritional Status
Correct iron deficiency before expecting aerobic training to move your VO2 max needle. The same applies to vitamin B12 deficiency (common in women on metformin long-term) and frank caloric restriction, which limits training adaptation regardless of effort.
Pregnancy and Lactation: What You Need to Know
Testing during pregnancy: Maximal exercise testing, including the Watt test to volitional exhaustion, is not recommended during pregnancy. ACOG Committee Opinion 804 (2020) endorses moderate-intensity physical activity throughout an uncomplicated pregnancy but specifies that women should avoid exercise to exhaustion. Submaximal assessments with continuous fetal heart rate monitoring are used in research settings but are not standard clinical practice.
Drug interactions during pregnancy: Several drugs that distort VO2 max results are also contraindicated or restricted during pregnancy. Beta-blockers are used in pregnancy for hypertension and certain arrhythmias but require specific obstetric oversight. GLP-1 agonists (semaglutide, tirzepatide, liraglutide) are contraindicated in pregnancy. Women of reproductive age on these medications should use reliable contraception, and the drugs should be stopped at least 2 months before a planned conception attempt, per the manufacturer's guidance for semaglutide. Statins are contraindicated in pregnancy. SSRIs are sometimes continued in pregnancy under careful risk-benefit discussion with an OB-GYN or psychiatrist.
Lactation: None of the drug classes discussed in this article require VO2 max testing as part of lactation monitoring. However, if you are postpartum and breastfeeding, note that iron depletion from pregnancy and blood loss compounds any pre-existing deficiency. Checking ferritin at the 6-week postpartum visit, before retesting VO2 max, is a reasonable step.
Who This Test Is Right For (and Who Should Wait)
Good Candidates
- Women aged 40 and older seeking a longevity baseline
- Women with PCOS, who carry elevated cardiovascular risk regardless of weight, and for whom VO2 max is a meaningful risk modifier
- Women entering perimenopause who want objective data on how their fitness is changing
- Women on GLP-1 agonists who want to monitor whether weight loss is preserving or eroding aerobic capacity
- Postpartum women at 6 weeks or beyond, cleared by their OB-GYN, looking to set a return-to-fitness baseline
Who Should Wait or Use Modified Protocols
- Women currently pregnant (defer to postpartum clearance)
- Women with uncontrolled hypertension, recent cardiac event, or active musculoskeletal injury
- Women with untreated or undertreated hypothyroidism (TSH out of range)
- Women with iron deficiency ferritin below 30 mcg/L (correct first, then test)
- Women currently on beta-blockers, where submaximal estimation will be invalid; direct gas-exchange testing is required if assessment is needed
How to Lower an Elevated VO2 Max (When That Might Apply)
A high VO2 max is almost never a clinical problem. The one context where this question sometimes arises is in competitive sports eligibility disputes or altitude physiology research, neither of which is the typical WomanRx reader scenario. If your VO2 max is flagged as unusually high and your provider wants to investigate, the priority is ruling out erythrocytosis (elevated red blood cell mass), which can occur with testosterone use, certain ovarian or adrenal tumors, or high-altitude adaptation, rather than trying to reduce the number.
Frequently asked questions
›What is a normal VO2 max level for a woman?
›What does a high Watt test or VO2 max mean?
›What does a low VO2 max mean?
›Does the menstrual cycle affect VO2 max test results?
›Do beta-blockers lower VO2 max?
›Can semaglutide or tirzepatide change my VO2 max?
›Is VO2 max testing safe during pregnancy?
›Does hormone therapy affect VO2 max in menopause?
›Can iron deficiency cause a low VO2 max?
›How do I raise my VO2 max as a woman in perimenopause?
›What drugs most commonly distort Watt test results?
References
- Kodama S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women. JAMA. 2009.
- Ross R, et al. Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign. Circulation. 2016.
- Blair SN, et al. Low cardiorespiratory fitness as a risk factor for multiple chronic conditions and mortality. Mayo Clin Proc. 2016.
- American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription, 10th ed. Normative data tables for women.
- Toth MJ, et al. Effect of menopause on cardiorespiratory fitness in healthy women. Menopause. 2020.
- ACOG Committee Opinion 804. Physical activity and exercise during pregnancy and the postpartum period. Obstet Gynecol. 2020.
- Lundby C, et al. Sex differences in VO2 max and determinants of cardiorespiratory fitness. J Appl Physiol. 2021.
- Wilmore JH, et al. Effect of beta-adrenergic blockade on exercise performance. J Appl Physiol. 1985.
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1 trial). N Engl J Med. 2021; body composition sub-analysis in Obesity 2023.
- Rechichi C, et al. Hormonal contraceptives and VO2 max in women: a meta-analysis. Sports Med. 2021.
- Mandigout S, et al. Effect of hormone therapy on cardiorespiratory fitness in postmenopausal women. Menopause. 2018.
- Wichniak A, et al. Cardiovascular effects of SSRIs during exercise testing. Br J Clin Pharmacol. 2019.
- World Health Organization. Worldwide prevalence of anemia 1993-2005. WHO Global Database on Anaemia. Geneva: WHO, 2008.
- Stagnaro-Green A. Postpartum thyroiditis. J Clin Endocrinol Metab. 2012.
- Mansi I, et al. Statins and musculoskeletal conditions, arthropathies, and injuries. JAMA Intern Med. 2013.
- Milanovic Z, et al. Effectiveness of high-intensity interval training (HIIT) and continuous endurance training for VO2 max improvements. Br J Sports Med. 2019.